RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Chante Karimkhani and colleagues1 highlighted the global burden of cutaneous leishmaniasis based on a cross-sectional analysis of data from the Global Burden of Disease Study 2013. Although the authors rightly point out that their study would be the first systematic attempt to quantify the disease, the methodological approach and the relevance of their findings to inform public health policy has to be questioned.